Fig. 4.

The change of body weights. On day 3 and 6, 1 × 10¹¹ pfu (200 μL) Ad/LacZ or Ad/IGFBP-3 was administered per rectal. Body weights were examined on the same time of the day. The DSS + Ad/IGFBP-3 group compared to the DSS + Ad/LacZ group. Pretreated Ad/IGFBP-3 group shows higher body weights than Ad/LacZ treated group's one on day 10 (P = 0.028). Mean ± SE. P < 0.05 was calculated by unpaired Student's t-test.

Ad/IGFBP-3 = adenoviral vector system expressing insulin-like growth factor-binding protein-3, DSS = dextran sodium sulfate, SE = standard error.